With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
In 2018 the USPSTF doubled back from advising against PSA screening to instead advising “individualized decision-making” which we now know preceded a significantly increasing trend of PSA testing across all Blue Cross Blue Shield beneficiaries ages 40-89. | Leapman, JAMA Oncol 2021